Goldman Sachs’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.6M | Sell |
700,000
-300,000
| -30% | -$16.3M | ﹤0.01% | 1795 |
|
|
2025
Q4 | $49M | Sell |
1,000,000
-800,000
| -44% | -$37.3M | 0.01% | 1521 |
|
|
2025
Q3 | $77.7M | Hold |
1,800,000
| – | – | 0.01% | 1107 |
|
|
2025
Q2 | $69.1M | Hold |
1,800,000
| – | – | 0.01% | 1125 |
|
|
2025
Q1 | $69.7M | Hold |
1,800,000
| – | – | 0.01% | 1000 |
|
|
2024
Q4 | $60.9M | Buy |
+1,800,000
| New | +$64.8M | 0.01% | 1132 |
|
|
2024
Q2 | – | Sell |
-136,100
| Closed | -$5.83M | – | 5757 |
|
|
2024
Q1 | $5.83M | Sell |
136,100
-1,384,600
| -91% | -$57.1M | ﹤0.01% | 2952 |
|
|
2023
Q4 | $56.4M | Buy |
1,520,700
+58,100
| +4% | +$2.09M | 0.01% | 1107 |
|
|
2023
Q3 | $53M | Buy |
1,462,600
+13,800
| +1% | +$490K | 0.01% | 1069 |
|
|
2023
Q2 | $51.6M | Sell |
1,448,800
-716,100
| -33% | -$25.7M | 0.01% | 1072 |
|
|
2023
Q1 | $77M | Buy |
+2,164,900
| New | +$75.7M | 0.02% | 800 |
|
|
2019
Q4 | – | Sell |
-8,000
| Closed | -$427K | – | 5295 |
|
|
2019
Q3 | $427K | Buy |
+8,000
| New | +$412K | ﹤0.01% | 4516 |
|
|
2019
Q2 | – | Sell |
-850,240
| Closed | -$44.4M | – | 5215 |
|
|
2019
Q1 | $44.4M | Buy |
+850,240
| New | +$42.5M | 0.01% | 1225 |
|
|
2018
Q4 | – | Sell |
-80
| Closed | -$4K | – | 5409 |
|
|
2018
Q3 | $4K | Hold |
80
| – | – | ﹤0.01% | 5516 |
|
|
2018
Q2 | $4K | Sell |
80
-800
| -91% | -$40.3K | ﹤0.01% | 5590 |
|
|
2018
Q1 | $43K | Sell |
880
-30,800
| -97% | -$1.43M | ﹤0.01% | 5512 |
|
|
2017
Q4 | $1.41M | Sell |
31,680
-53,040
| -63% | -$2.45M | ﹤0.01% | 4061 |
|
|
2017
Q3 | $4.3M | Buy |
84,720
+53,280
| +169% | +$2.7M | ﹤0.01% | 3298 |
|
|
2017
Q2 | $1.7M | Sell |
31,440
-8,560
| -21% | -$456K | ﹤0.01% | 3968 |
|
|
2017
Q1 | $2.11M | Sell |
40,000
-69,360
| -63% | -$3.52M | ﹤0.01% | 3692 |
|
|
2016
Q4 | $5.26M | Buy |
109,360
+27,520
| +34% | +$1.36M | ﹤0.01% | 3007 |
|
|
2016
Q3 | $4.41M | Sell |
81,840
-18,640
| -19% | -$1.02M | ﹤0.01% | 3146 |
|
|
2016
Q2 | $5.44M | Buy |
100,480
+52,800
| +111% | +$2.78M | ﹤0.01% | 2801 |
|
|
2016
Q1 | $2.42M | Sell |
47,680
-118,160
| -71% | -$5.89M | ﹤0.01% | 3305 |
|
|
2015
Q4 | $8.37M | Buy |
165,840
+10,720
| +7% | +$546K | ﹤0.01% | 2391 |
|
|
2015
Q3 | $7.46M | Sell |
155,120
-3,440
| -2% | -$179K | ﹤0.01% | 2510 |
|
|
2015
Q2 | $8.26M | Sell |
158,560
-50,160
| -24% | -$2.82M | ﹤0.01% | 2502 |
|
|
2015
Q1 | $12M | Sell |
208,720
-33,920
| -14% | -$1.94M | ﹤0.01% | 2138 |
|
|
2014
Q4 | $13M | Sell |
242,640
-93,200
| -28% | -$5.21M | ﹤0.01% | 2142 |
|
|
2014
Q3 | $19.3M | Buy |
335,840
+141,360
| +73% | +$8.67M | 0.01% | 1811 |
|
|
2014
Q2 | $13M | Sell |
194,480
-27,280
| -12% | -$1.85M | ﹤0.01% | 2153 |
|
|
2014
Q1 | $14.8M | Sell |
221,760
-589,680
| -73% | -$39.9M | ﹤0.01% | 2019 |
|
|
2013
Q4 | $54.2M | Sell |
811,440
-125,040
| -13% | -$8.11M | 0.02% | 987 |
|
|
2013
Q3 | $58.7M | Buy |
936,480
+104,080
| +13% | +$6.7M | 0.02% | 873 |
|
|
2013
Q2 | $52M | Buy |
+832,400
| New | +$52.8M | 0.02% | 883 |
|
Other funds holding GSK
JEST
Goldman Sachs's GSK Position: Q1 2026 in Review
Goldman Sachs increased its GSK (GSK) stake by 32% in Q1 2026, buying an estimated $127M and bringing the position to 9,589,114 shares worth $529M. The position accounts for 0.06% of the portfolio, ranked #324.
Goldman Sachs first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Goldman Sachs held 9,589,114 shares of GSK worth $529M as of Q1 2026.
- Goldman Sachs bought 2,347,296 GSK shares in Q1 2026, an estimated $127M.
- GSK made up 0.06% of Goldman Sachs's portfolio in Q1 2026, its #324 holding.
- Goldman Sachs first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.